Krishna Institute of Medical Sciences Closes Qualified Institutions Placement (QIP) with Allocation of Nearly 20 Million Shares
Krishna Institute of Medical Sciences Limited announced the closure of its Qualified Institutions Placement (QIP), following a meeting of its Finance and Investment Committee held on June 19, 2026. The company approved the allocation of Equity Shares to eligible qualified institutional buyers.The committee's resolutions confirmed that the issue period was closed after receiving application forms and funds in the escrow account from qualifying institutional buyers. This placement activity marked a key operational step for the company as it finalized the sale of its stock.
The Finance and Investment Committee approved the details of the allocation, which involved 19,867,549 Equity Shares being allotted to qualified institutional buyers at an issue price of ₹ 755 per Equity Share. This price included a premium of ₹ 753 per Equity Share, factoring in a discount of ₹ 16.73 per Equity Share, which represented 2.17% of the floor price.
Key details regarding the placement closure include:
| Metric | Detail |
|---|---|
| Issue Closure Date | June 19, 2026 |
| Total Shares Allocated | 19,867,549 |
| Final Issue Price | ₹ 755 per Equity Share |
| Premium | ₹ 753 per Equity Share |
| Discount (from Floor) | ₹ 16.73 per Equity Share (2.17%) |
The company also approved and adopted the placement document on June 19, 2026, confirming details related to the Issue. Further actions approved included finalizing the confirmation of allocation notes for eligible qualified institutional buyers and approving the issuance of refund intimation letters where applicable. The placement was initially opened on June 16, 2026.
KIMS Stock Price Movement
Krishna Institute of Medical Sciences Limited shares gained significantly today, closing at ₹804.25 after rallying 2.15% in post-market trading. The stock achieved its 52-week high, completing the session with robust buying interest reflected by a volume of 761,160 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.